Figure 2 | Scientific Reports

Figure 2

From: Metabolomics profiling distinctively identified end-stage renal disease patients from chronic kidney disease patients

Figure 2

(A) PLS-DA scores plot (R2X: 0.43, R2Y:0.84, Q2 0.75) of the three study groups; controls (blue), ESRD (red) and CKD (green). (B) Hierarchal clustering (HAC) and heatmap analysis of the top 50 significantly altered metabolites between the three study groups; controls (blue), ESRD (red) and CKD (green). ESRD end-stage renal disease, CKD chronic kidney disease.

Back to article page